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Summary
Storage methods, which can be taken into consideration 
for red blood cells and platelets, include liquid storage, 
cryopreservation and freeze-drying. Red blood cells can 
be hypothermically stored at refrigerated temperatures, 
whereas platelets are chilling sensitive and therefore can-
not be stored at temperatures below 20 °C. Here we give 
an overview of available cryopreservation and freeze-dry-
ing procedures for blood cells and discuss the effects of 
these procedures on cells, particularly on cellular mem-
branes. Cryopreservation and freeze-drying may result in 
chemical and structural modifications of cellular mem-
branes. Membranes undergo phase and permeability 
changes during freezing and drying. Cryo- and lyoprotec-
tive agents prevent membrane damage by different mech-
anisms. Cryoprotective agents are preferentially excluded 
from membrane surfaces. They decrease the activation 
energy for water transport during freezing and control the 
rate of cellular dehydration. Lyoprotectants are thought to 
stabilize membranes during drying by forming direct hy-
drogen bonding interactions with phospholipid head 
groups. In addition, lyoprotectants can form a glassy state 
at room temperature. Recently liposomes have been in-
vestigated to stabilize blood cells during freezing and 
freeze-drying. Liposomes modify the composition of cel-
lular membranes by lipid and cholesterol transfer, which 
can stabilize or destabilize the low temperature response 
of cells.
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Zusammenfassung
Theoretisch existieren drei Methoden zur Lagerung roter 
Blutkörperchen und Blutplättchen: in der flüssigen Phase, 
eingefroren oder gefriergetrocknet. Rote Blutkörperchen 
können gekühlt bei etwa 4 °C gelagert werden, wobei Blut-
plättchen empfindlich gegenüber Abkühlung sind und 
nicht kälter als bei Raumtemperatur aufbewahrt werden 
dürfen. Diese Übersichtsarbeit befasst sich mit den gegen-
wärtig bekannten Prozeduren zur Kryokonservierung und 
Gefriertrocknung von Blutzellen, außerdem wird die Aus-
wirkung dieser Prozesse auf die Zellen und insbesondere 
deren Membranen diskutiert. Sowohl die Kryokonservie-
rung als auch die Gefriertrocknung können zu chemischen 
und strukturellen Veränderungen in Zellmembranen füh-
ren. Außerdem kann es zu Phasenwechseln und Permeabi-
litätsänderungen während des Einfrierens und Trocknens 
kommen. Kryo- und Lyoprotektiva schützen Zellmembra-
nen aufgrund unterschiedlicher Wirkmechanismen, wobei 
Kryoprotektiva bevorzugt von der Zelloberfläche ausge-
schlossen werden. Sie senken die Aktivierungsenergie für 
Wassertransport während des Einfrierens und Kontrollie-
ren den Grad der Wasserabgabe der Zellen. Bei Lyoprotek-
tiva hingegen wird davon ausgegangen, dass sie während 
des Trocknungsvorgangs Wasserstoffbrücken mit den 
Kopfgruppen der Phospholipide in der Membran bilden. 
Außerdem können Lyoprotektiva schon bei Raumtempera-
tur vitrifizieren. Vor kurzem wurde auch die Einwirkung 
von Liposomen auf rote Blutkörperchen während des Ein-
frierens und des Gefriertrocknens untersucht. Liposomen 
modifizieren die Zusammensetzung der Zellmembran 
durch Transfer von Lipiden und Cholesterin, was die Reak-
tion der Zellen auf niedrige Temperaturen verändern kann.
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during storage of RBCs include flip-flop of phosphatidyl ser-
ines, which relocate from the inner membrane leaflet to the 
outer membrane leaflet. An increased phosphatidyl serine 
concentration in the outer membrane leaflet is thought to 
mediate RBC clearance by macrophages [1]. Membrane 
damage during storage is also caused by accumulation of 
lipid peroxidation products, which decrease membrane in-
tegrity and cause hemolysis [5]. Hypothermic storage causes 
reorganization of the membrane microstructure, e.g. the 
 reorganization of lipid raft proteins such as stomatin and flo-
tillins or accumulation of membrane proteins damaged by 
oxidation throughout storage [6, 7].
Platelets
Storage of platelets is a major problem in blood banks be-
cause cooling of platelets below 20 °C causes cold-induced 
activation. Platelets are activated by refrigeration and can 
only be stored at temperatures of at least 20 °C. Activated 
platelets are rapidly taken out of circulation in a transfusion 
recipient [8, 9]. Moreover, storage of platelets at ambient 
temperatures allows for the possibility of bacterial growth, 
and this can have fatal consequences for a recipient. Cold 
shock damage in platelets and other cells has been linked to 
lipid phase transitions that cause the membrane to become 
transiently leaky [10, 11]. Cooling alters the phase state and 
structural organization of membrane components, leading to 
coalescence of lipid rafts in membranes, events that appear to 
be irreversible on warming [12]. Platelets exhibit two phase 
transition temperatures between 0 and 45 °C. The main lipid 
phase transition between 10–20 °C coincides with increases in 
Ca2+ fluxes and morphological changes [13]. A second, 
smaller phase transition at around 30 °C is thought to arise 
from the melting of lipid rafts [12]. Under physiological con-
ditions, membranes are thought to be in the fluid state. Cool-
ing causes lateral phase separation of membrane components 
to the point of macroscopic visible rafts. Rafts are thought as 
cell signaling platforms, which in case of platelets mimic 
thrombin induced activation [14]. When platelets are stored 
for longer than 24 h at 4 °C, cooling-induced changes in mem-
brane structure become irreversible and activation takes 
place. Liquid stored platelets at 22 °C have a mandated shelf-
life of 4 days in Germany. Coalescence of lipid rafts is not 
observed in RBCs [15]. This is likely due to the relatively 
high membrane cholesterol content of RBCs preventing coa-
lescence of rafts.
Cryodamage
The major stresses on membranes during cryopreservation 
are fusion- and freezing-induced membrane phase transitions 
which can lead to an increase in permeability and lateral 
phase separation of specific phospholipid classes, cholesterol 
or proteins [16]. The main driving force for phase separation 
Introduction
Proper storage of blood cells still poses major problems in 
blood banks. Long-term storage of these blood cells is crucial 
to ensure permanent availability for clinical use. Blood trans-
fusions are used for trauma victims, surgery, organ transplants 
and patients receiving treatment for leukemia, cancer or other 
diseases such as sickle cell disease and thalassemia. Due to a 
steadily increasing demand of blood products, there is a need 
to improve currently applied storage methods to avoid short-
ages. The main blood cell products are concentrates of red 
blood cells (RBCs) and platelets. Storage methods for blood 
cells include liquid storage and may include cryopreservation. 
So far, freeze-drying is not applicable in the case of any blood 
component where viable cells are needed for patient treat-
ment. RBCs are stored hypothermically at temperatures in 
the range of 2–6 °C. Platelets are chilling sensitive and there-
fore cannot be stored at lower temperatures: They need to be 
stored at least at ambient temperatures to avoid chilling in-
jury. Cryopreservation does in certain cases and freeze-drying 
may provide alternative storage methods, however, there is 
always the danger that they damage cellular structures. Mem-
branes are considered as the primary site of biopreservation 
injury. In the following, we provide an overview on biopreser-
vation-related stress factors on blood cell membranes, mecha-
nisms of membrane stabilization and recent advances in bio-
preservation of blood cells using membrane modification 
strategies.
Mechanisms of Injury during Biopreservation
Damage by Hypothermic Storage
RBCs
In Germany (and other European countries) erythrocytes 
can be stored at 2–6 °C for up to 42 (or 49) days in additive 
solutions such as SAG-M (or PAGGS-M). With increasing 
storage time, however, blood cell quality decreases, com-
monly accepted measures are lower ATP and 2,3-DPG 
 levels [1]. Since metabolic processes at temperatures around 
4 °C are only slowed down and not completely suppressed, 
they are one of the main causes of storage injury. RBCs 
show a decrease in deformability and a change in shape from 
normal smooth discoid to an echinocyte shape or spheroid 
shape with specula. These changes are initially reversible, 
but become irreversible after prolonged storage. The shed-
ding of microvesicles is also considered as a sign of aging 
during storage. These phospholipid- and cholesterol-rich 
vesicles of less than 500 μm segregate from stored RBCs 
over time, but their function is largely unknown. It has been 
speculated that this is a way for the cells to get rid of delete-
rious compounds [2–4]. The effects of storage are particu-
larly visible at the membrane level. Membrane alterations 
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during freezing. Freezing causes removal of the bound water 
around the phospholipid head groups, resulting in lyotropic 
phase transitions [18]. Freezing-induced phase transitions are 
usually stronger and more cooperative compared to those at 
supra-zero temperatures [19].
One key membrane property determining the faith of a cell 
after freezing and thawing is the membrane permeability to 
water. The cell-specific membrane hydraulic permeability 
 determines the optimal cooling rate needed to minimize cryo-
preservation damage. For cells undergoing freezing, a two-
factor hypothesis of damage has been developed [for review 
see 20]. At high cooling rates, cell losses are associated with 
intracellular ice formation. For cells cooled slowly, damage is 
described as ‘solution effects injury’, which is related to cellu-
lar dehydration. Typically, there is a critical cooling rate for 
maximum survival. This cooling rate, however, varies greatly 
depending upon the cell type and is related to the cell-specific 
membrane permeability to water [21–23]. Freezing causes 
fluid-to-gel phase transitions affecting the membrane hydrau-
lic permeability and the activation energy for water transport. 
Figure 1 shows the effects of the ice nucleation temperature 
on membrane phase behavior: high sub-zero nucleation tem-
peratures (dehydrating freezing conditions) cause strong 
fluid-to-gel phase transitions. Figure 2 illustrates the effect of 
different cooling conditions on cells and on membrane phase 
state. Dehydrating freezing conditions cause fluid-to-gel 
phase transitions, whereas conditions resulting in intracellular 
ice formation leave the membranes in a relatively fluid state. 
The freezing-induced effects on membrane phase state also 
affect the cell’s membrane permeability to water at sub-zero 
temperatures. The membrane hydraulic permeability at sub-
zero temperatures differs substantially from the one above 
the freezing point [24]. RBCs are extremely permeable to 
water, and hence the optimal cooling rate is extremely high at 
approximately 2,500 K/min [25], which can hardly be reached 
in the sample volumes as required for therapeutically usable 
blood.
is the hydrophobic mismatch between membrane components 
such as lipids with different acyl chain length or between lip-
ids and proteins. The greater the differences in thickness, the 
more hydrophobic residues are exposed to water. During 
cooling lipids undergo fluid-to-gel phase transitions, which 
cause a thickening of lipid bilayers, due to straightening of 
disordered acyl chains. By cooling the fraction of lipids in the 
fluid state decreases or disappears, thus the hydrophobic mis-
match between the different species diminishes, too. As a re-
sult, specialized membrane domains (rafts) dissipate during 
cooling [17]. Membranes are exposed to severe dehydration 
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Fig. 1. Membrane phase behavior of LNCaP tumor cells during cooling 
and nucleation at various sub-zero temperatures. The data points reflect 
νCH2 during freezing the cells down to –80 °C. Samples were nucleated at 
–3 °C (filled squares), –6 °C (open triangles) or at –10 °C (open circles). 
Data are adapted from [18].
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Fig. 2. Schematic representation illustrating 
the effects of freezing on cells and cellular 
membranes. The small grey filled circles repre-
sent water and the star shaped asterisks repre-
sent ice crystals. Slow freezing and high sub 
zero nucleation result in cellular dehydration 
and gel phase formation in membranes. Fast 
freezing and low ice nucleation temperatures 
(supercooling) result in intracellular ice forma-
tion. Membranes remain relatively hydrated 
and the residual conformational disorder of 
membranes is greater compared to dehydrated 
cells. This figure is adapted from [71].
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Membrane Stabilization during Cryopreservation and 
Freeze-Drying
Cryopreservation
There are several theories that describe how cryoprotective 
agents protect membranes and proteins in cells during freez-
ing stress. The preferential exclusion theory [33, 34] is based 
on the observation that molecules such as compatible solutes 
are excluded from protein surfaces, which leads to a state of 
preferential hydration for the protein surface. Compatible 
 solutes are small organic osmolytes including sugars, polyols, 
amino acids, and derivatives thereof that are compatible with 
cell metabolism even at molar concentrations [35]. A consid-
erable number of these compatible solutes possesses cryopro-
tective properties. Stabilization of proteins (and cell mem-
branes) during freezing requires a co-solute that is preferen-
tially excluded from the protein surface [16, 36]. The solute’s 
exclusion from the surface of the protein is thermodynami-
cally unfavorable, since it results in a decrease in entropy of 
the system. A protein in its native conformation exposes the 
smallest surface area and is thus the thermodynamically most 
favorable state. Preferential exclusion increases the energy 
barrier for protein denaturation [16]. A preferential binding 
solute will destabilize a protein since energy is released upon 
binding of the solute with the protein, which promotes unfold-
ing of the protein. Nearly all known stabilizing solutes are 
 excluded from protein surfaces. Studies on the effect of com-
patible solutes on membrane systems suggest that compatible 
solutes are also preferentially excluded from the membrane-
solvent interface [37].
Recent studies have demonstrated how cryoprotective 
agents such as glycerol or dimethyl sulphoxide (DMSO) affect 
sub-zero membrane phase behavior and membrane hydraulic 
permeability parameters of mammalian cells [24, 38]. Interest-
ingly, freezing-induced membrane phase changes are not pre-
vented in the presence of cryoprotective additives (CPA) but 
they occur more gradual over a wider temperature regime. 
CPAs decrease the activation energy for water transport dur-
ing freezing, particularly the transport of membrane-bound 
Freeze-Drying Damage
Intuitively freeze-drying seems to be one of the most attrac-
tive methods for blood cell storage, and the ultimate goal is 
storage in the dried state at room temperature. From what 
we know today, freeze-drying, however, is also more dam-
aging to macromolecular and cellular structures compared 
to freezing. For lyophilization a sample is first frozen to 
crystallize the solvent (water) and to separate it from the 
solutes. Subsequently the solvent content is reduced by 
sublimation and desorption to levels that are known to 
strongly reduce chemical reactions [26]. Thus, the process 
of freeze-drying contains two different steps that may be 
harmful for cells: a freezing step followed by a drying step. 
Although freezing and drying are different stress factors, 
there are similarities between the two processes [16]. The 
removal of intracellular water causes drastic changes in 
inter- and intramolecular interactions. Upon drying, intra-
cellular proteins and membranes compensate the loss of 
 hydrogen bonding with water by forming hydrogen bonds 
with other molecules. This results in forced intermolecular 
interactions between molecules that normally would not in-
teract with each other in the presence of bulk water, but 
will do so upon dehydration. In proteins, the loss of hydro-
gen bonds with water can be compensated by protein-pro-
tein interactions and may thus lead to protein aggregation 
or denaturation [27–29]. Dehydration-induced protein-pro-
tein interactions can lead to irreversible conformational 
changes and, in enzymes, to a loss of enzymatic activity 
[30]. In membranes, water loss from the phospholipid head 
groups may lead to phase transitions from the biologically 
active fluid phase to the gel phase [31, 32]. In addition, 
freezing and drying result in accumulation of reactive oxy-
gen species causing chemical modifications including for-
mation of free fatty acids. The effects of freezing and drying 
on membranes are illustrated in figure 3. A small fraction 
of nonfreezable water usually remains with the phospholi-
pid head groups. When this water fraction is removed by 
drying in absence of lyoprotectiva, membrane injury occurs 
by fusion with other membranes.
Fig. 3. Schematic representation illustrating 
the physical and chemical effects of freezing 
and drying on membrane lipid phase state, 
membrane organization, and chemical lipid 
 stability. The simplified membrane is com-
posed of lipids, cholesterol and transmembrane 
proteins. Damaging events occurring during 
freezing and desiccation include gel phase for-
mation, reorganization of cholesterol, protein 
aggregation, and accumulation of free fatty 
acids.
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water entrapment hypothesis. The water replacement theory 
proposed by Crowe and co-workers [reviewed in 17] is based 
on their studies on anhydrobiotic organisms which are able to 
loose almost all of their cellular water but are nevertheless 
able to return to full activity after rehydration. Protection is 
assigned to certain compatible solutes, particularly nonreduc-
ing disaccharides, and their direct interactions with mem-
branes and proteins. In this model, the hydrogen bonding in-
teractions which are provided by water in the hydrated state 
are replaced in the dried state by these solutes (fig. 4). On the 
other hand, the water entrapment hypothesis postulates that, 
in the dry state, sugars rather than direct binding to biomole-
cules entrap the residual water at the interface with the bio-
molecule [41, 42]. In this model, a critical amount of bound 
water around macromolecular structures is considered to be 
necessary for protection in the dried state. In a recent study, 
we have shown that water entrapment rather than water re-
placement explains the effect of trehalose on lipid phase be-
havior of lipid bilayers during the initial phase of drying [43].
Moreover, in order to achieve stability of a freeze-dried 
formulation at ambient temperatures, the formulation needs 
to be in a glassy state. Due to the extremely high viscosity of 
the vitreous state, the rate of deleterious reactions would be 
very low, since most physical and chemical processes are dif-
fusion-limited. Thus, transition in the glassy state results in 
immobilization of cellular structures and biochemical compo-
nents, which preserves their biological function [44]. The rea-
son why disaccharides are used instead of monosaccharides 
in freeze-drying protocols is related to the difference regard-
ing the glass transition temperature. The glass transition tem-
perature of a formulation based on monosaccharides is lower 
water [24]. These effects of CPAs on membrane hydraulic 
permeability parameters have some important practical appli-
cations as they result in a decrease of the optimal cooling rate 
for cryopreservation to technically more easily achievable 
rates. RBCs, for example, require extremely high cooling 
rates in the absence of cryoprotective agents [25]. In the pres-
ence of 40% glycerol, however, slow cooling rates can be used 
to obtain maximum survival after freezing and thawing [39].
Other protective mechanisms of CPAs include their effects 
on ice crystallization and formation of a glassy state. A freeze-
concentrated solution pass into a highly viscous glassy state at 
a characteristic glass transition temperature, immobilizing the 
product and thus preventing degradation reactions. Iijima [40] 
has conducted a study using differential scanning calorimetry 
(DSC) on the thermal behavior of glycerol-water solutions 
(binary system) and the more complex glycerol-based cryo-
protective solutions that are used clinically for cryopreserva-
tion of RBCs. 
Freeze-Drying
In contrast to freezing, the requirements for solute specificity 
are more stringent in the case of drying; only certain sugars 
are effective and stabilization requires direct interaction be-
tween the sugar and polar residues in the protein or phosphol-
ipid [16]. The preferential exclusion model is valid for the 
more diluted range of solute concentrations and therefore 
cannot be extrapolated to dried systems. The two central hy-
potheses proposed for sugar-biomolecule interactions in the 
dried state are the water replacement hypothesis and the 
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Fig. 4. Schematic representation illustrating 
the effects of drying on lipid conformation in 
the dried state. The grey filled circles represent 
water and the grey filled squares represent 
 sucrose. Drying in the absence of a protectant 
(sucrose) results in a liquid crystalline to gel 
phase transition during dehydration and vice 
versa during rehydration. The liquid crystalline 
phase is maintained during drying (and rehy-
dration) in presence of a protectant. This idea 
has been postulated as the water replacement 
hypothesis [31, 32].
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In the 1970s when no filter systems were available for the 
 removal of leukocytes, cryopreservation followed by deglyc-
erolization has been used for the removal of contaminating 
leukocytes from packed RBCs. The first more or less success-
ful attempts to store platelets for prolonged time were done 
using DMSO as the cryoprotective agent. Human platelets 
frozen in DMSO can survive and function after transfusion. 
This cryopreservation method increases shelf-life to at least 
1 year, but requires washing and processing to remove the 
DMSO which is not well tolerated by the human body. The 
accepted method for cryopreservation of platelets (if at all) 
uses DMSO at a concentration of 6% in the suspension to be 
frozen [51, 52].
Freeze-Drying
Much effort has been put in the invention of procedures that 
stabilize cells in the dried state at ambient temperatures [26]. 
Apart from drying, freeze-drying has become the standard 
method to remove bulk water from liquid samples. Freeze-
drying was used in World War II for preservation of blood 
plasma (which is cell-free) for use as a resuscitation fluid and 
restoration of coagulation deficiencies. Nowadays, freeze-dry-
ing has become a standard procedure for certain proteins. 
However, successful dehydration and rehydration of cells is 
much more complicated. In 1956, Klein and coworkers [53] 
reported on their results in testing the procoagulant proper-
ties of a freeze-dried preparation made from an extracted 
platelet suspension. Chemical fixation methods have also 
been used in attempts to stabilize cells during drying. Read et 
al. [54] applied a fixation with paraformaldehyde to enhance 
osmotic stability of platelets during freeze-drying. The ul-
trastructural integrity of these platelets looked as if preserved 
upon rehydration, and the platelets were reported as being 
 capable of adhering to subendothelium and of spreading on 
an inert surface. Lyophilized fixed platelets have been shown 
to reduce the bleeding time in dogs on cardiopulmonary by-
pass [55]. A major disadvantage of this method is that para-
formaldehyde irreversibly cross-links with membranes and 
proteins and therefore modifies platelets chemically. This 
modification is likely to impair proper functioning in 
hemostasis.
Recent attempts to freeze-dry mammalian cells have fo-
cused on the introduction of disaccharides into the cells. The 
use of nonreducing disaccharides such as trehalose and su-
crose has been inspired by nature’s way for the preservation 
of life in the anhydrobiotic state in some species [reviewed in 
32]. Some anhydrobiotic organisms rely on accumulation of 
large quantities of disaccharides which, in combination with 
other protective compounds (i.e. LEA proteins, antioxidants), 
allow them to revive after rehydration. The major problem 
when using disaccharides for the lyopreservation of mamma-
lian cells is to overcome the impermeability of cell membranes 
compared to one based on disaccharides [45]. Moreover, 
freeze-dried formulations based on reducing monosaccha-
rides are chemically unstable due to Amadori and Maillard 
reactions [46].
Recent Advances in Biopreservation of Blood Cells
Cryopreservation
The driving force for the development of cryopreservation 
methods for RBCs differs from that of platelets. RBCs are 
quite stable over a rather long (i.e. weeks) hypothermic stor-
age period. Cell quality, however, decreases during storage. In 
addition, liquid storage has always been a problem in the case 
of extremely rare blood groups, especially in the case of 
 already existing antibodies. For platelets, cryopreservation 
seems to be even more attractive, as platelets can be stored 
unfrozen only for a very limited time period (days)
Cryopreservation procedures for RBCs have been devel-
oped in the beginning of the second half of the last century. 
Techniques using glycerol as cryoprotective agent either need 
a high glycerol content (40%) combined with a low cooling 
rate, or a low glycerol content (17–20%) in combination with 
a high cooling rate is required [39, 47]. The main disadvan-
tage of these procedures is the subsequent deglycerolization 
process required after thawing. RBCs which contain more 
than ~2% glycerol lyse in an isotonic medium (such as circu-
lating blood plasma) medium due to osmotic stress. The 
deglycerolization process is also difficult to handle when try-
ing to maintain sterile conditions (which is highly important 
when the washed units are not directly transfused). An op-
tion to circumvent post-thaw washing procedures is the ap-
plication of nontoxic high-molecular-weight extracellular ad-
ditives. For the cryopreservation of RBCs polyvinylpyro-
lidone (PVP) and hydroxyethyl starch (HES) have been ap-
plied. Especially the latter has received some attention in 
transfusion medicine. Additives like HES and PVP do not 
penetrate the cell membrane, but the protective mechanisms 
of these molecules are not yet completely understood. They 
affect the kinetics of ice nucleation and crystal growth; both 
are good glass formers, and because of their considerable col-
ligative properties at high concentrations they may cause 
 dehydration of the cell. Freezing of RBCs in the presence of 
11.5% w/w HES yields over 90% viable cells after thawing in 
terms of saline stability [48]. It has been demonstrated in a 
systematical clinical study with autologous RBCs that at least 
one unit of frozen/thawed packed RBCs could be re-infused 
without any post-thaw washing step [49]. The main advantage 
of HES over PVP is that it is quickly removed from the or-
ganism and that HES (in contrast to PVP) is a biodegradable 
compound which is eliminated from the circulation [50]. 
However, despite of existing cryopreservation protocols, cry-
opreservation of blood cells is no longer used on a large scale. 
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[60]. In this study a combination of glucose and HES was used 
to protect the cells. Rehydrated RBCs were shown to synthe-
size ATP and 2,3-DPG, and the activities of catalase and su-
peroxide dismutase were preserved. However, this approach 
has been discontinued, and there is evidence that these RBCs 
were not truly ‘dry’, as only water contents at or below ap-
proximately 5% can be regarded as ‘dry’ under practical as-
pects. Additionally, the intactness of enzymes is sufficient for 
the explanation of some metabolic activities, but this is only 
one sine qua non (and not a sufficient one) for a viable cell. 
Later studies reported on the use of intracellular trehalose for 
freeze-drying of RBCs [61, 62]. In these studies in which 
RBCs were loaded with trehalose by an osmotic shock proce-
dure to achieve intracellular lyoprotection, and recovery rates 
of about 55% have been reported. A follow-up study of this 
work [63] showed the synergistic effects of liposomes in com-
bination with trehalose which will be elaborated on in the 
next section. Using this approach, increased recovey rates of 
about 70% could be achieved [63]. Despite the above men-
tioned efforts, neither freeze-dried RBCs nor freeze-dried 
platelets are presently used for patient treatment.
Membrane Modification Strategies
Since membranes are the primary site of biopreservation in-
jury, efforts to modify cell membranes have been undertaken 
to improve the response of mammalian cells during cooling or 
drying. Membrane modification strategies rely on liposomes 
or cyclodextrin to add or extract cellular lipids and choles-
terol. The stabilizing effect of liposomes on bull spermatozoa 
is known for some time [64]. Recently, liposomes have been 
investigated as protective agents for cryopreservation and 
freeze-drying of RBCs [63, 65]. The effect of liposomes is con-
sidered to be due to lipid and cholesterol transfer between 
 liposomes and cells. In a recent study, we have shown that 
 liposomes extract cholesterol from RBC membranes [66]. In 
addition, lipid transfer from lipids inside of liposomes to RBC 
membranes was observed. Lipid and cholesterol transfer be-
tween liposomes and cells are dependent on the chemical lipid 
properties. Rapid lipid and cholesterol transfer is observed 
when RBCs are incubated with 1,2-dilauroyl-sn-glycero-3-
phosphocholine (DLPC), which has relatively short acyl chain 
lengths of 12 CH2 groups. Treatment of RBCs with DLPC 
 liposomes drastically affects the membrane phase behavior 
of RBC membranes (fig. 5). In contrast, 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC) displays a much slower 
lipid and cholesterol exchange with RBCs. Depletion of cho-
lesterol changes membrane properties. It causes an increase 
in lipid disorder, and it increases bilayer thickness [67, 68]. Al-
teration of the cell membrane cholesterol content can either 
enhance or decrease the low temperature response of cells 
[69]. In addition, liposomes influence the cell’s permeability 
to membrane-permeating cryoprotectants. It could be shown 
to such disaccharides without disrupting the cellular structure. 
Guo et al. [56] have tackled this problem by expressing the 
genes that encode for trehalose-6-phosphate synthase and tre-
halose 6-phosphate phosphatase in human foreskin fibro-
blasts. They have shown that cells modified in this way are 
able to accumulate trehalose. However, the survival rates and 
longevity of these cells after drying were found to be rather 
poor. Another method proposed for the incorporation of 
 trehalose into platelets is fluid phase endocytosis. Platelets 
have a relatively high surface-to-volume ratio compared to 
other cells, so they have been found to take up trehalose rap-
idly at 37 °C by fluid phase endocytosis [57]. In vitro treha-
lose-loaded freeze-dried platelets have been shown to respond 
to various platelet agonists. Platelet recovery rates amount to 
approximately 90%, and they were stable in the dried state. 
Subsequently, a procedure has been developed to freeze-dry 
whole platelet concentrates in specially designed lyophiliza-
tion bags with one semipermeable site allowing water trans-
port during freeze-drying [58]. However, as demonstrated by 
flow cytometric investigations, these platelets showed ele-
vated levels of various platelet activation markers, which 
could be interpreted as a form of platelet damage. Recent 
 activities focus on the use of freeze-dried platelets in topical 
wound healing [59], as in such preparations the platelets do 
not necessarily need to be viable.
One of the most frequently cited reports regarding the 
freeze-drying of RBCs is the one by Goodrich and co-workers 
WHPSHUDWXUHR&
     
Q&
+ 
F
P
 





'/3&WUHDWHG5%&V
XQWUHDWHGFRQWURO5%&V
7H SHUDWXUH
Q&
+ 
F
P±

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liposome-treated RBCs (open circles) and liposome treated RBCs (filled 
circles). Data are adapted from [66].
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Interestingly, one of the advantages of liposomes is that 
 lipids that have been shown to be effective stabilizers are usu-
ally natural, nontoxic phospholipids; therefore a removal after 
preservation is not necessary.
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that cholesterol-depleted cells have an increased permeability 
for glycerol [70].
For cryopreservation and freeze-drying, especially lipo-
somes made from unsaturated lipids were shown to possess 
cryoprotective properties for RBCs. Kheirolomoom et al. 
[63] have speculated that liposomes may be able to repair 
transient membrane disruptions that occur during the stress-
ful procedure of freezing and drying. The liposome technol-
ogy is not yet ready for the hypothermic unfrozen storage of 
RBCs. There is evidence that liposomes composed of un-
saturated lipids destabilize RBCs during hypothermic stor-
age and cause increased hemolysis, whereas liposomes com-
posed of certain saturated lipids possess stabilizing proper-
ties during hypothermic storage (Stadnick et al. unpublished 
results).
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